# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-26-094544
Filing Date
2026-08-12
Accepted
2026-08-12 08:40:46
Documents
44
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | apre-20260630x10q.htm iXBRL | 10-Q | 1580593
2 | EX-31.1 | apre-20260630xex31d1.htm | EX-31.1 | 10244
3 | EX-31.2 | apre-20260630xex31d2.htm | EX-31.2 | 10712
4 | EX-32.1 | apre-20260630xex32d1.htm | EX-32.1 | 6464
5 | EX-32.2 | apre-20260630xex32d2.htm | EX-32.2 | 6887
| Complete submission text file | 0001104659-26-094544.txt |  | 4401880

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | apre-20260630.xsd | EX-101.SCH | 27876
7 | EX-101.CAL | apre-20260630_cal.xml | EX-101.CAL | 28814
8 | EX-101.DEF | apre-20260630_def.xml | EX-101.DEF | 102756
9 | EX-101.LAB | apre-20260630_lab.xml | EX-101.LAB | 251242
10 | EX-101.PRE | apre-20260630_pre.xml | EX-101.PRE | 171791
48 | EXTRACTED XBRL INSTANCE DOCUMENT | apre-20260630x10q_htm.xml | XML | 404903

Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 215-948-4119
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39069 | Film No.: 261265453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)